drugset / Trial / NCT01538849
Study to Investigate the Safety, Tolerability and Efficacy of YH4808 in Patients With Reflux Esophagitis
RandomizedParallel-groupDouble-blindTreatment
Summary
This study is to investigate the optimal clinical dose and administration methods of YH4808 in patients with reflux esophagitis by evaluating the safety and efficacy after YH4808 oral administration.
Timeline
- Start
- 2012-12
- Primary completion
- 2013-11
- Completion
- 2014-05
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Esomeprazole | Small molecule | 40 mg | Oral |
| Subject | YH4808 | Other / unclassified | — | Oral |